The world of vaccines, before and after COVID

The COVID-19 pandemic has forever changed the world's relationship to vaccines, spurring unprecedented production and innovation even while poorer nations were left behind.


Pfizer sees Covid-19 drug sales topping $50 bn in 2022

Pfizer forecast more than $50 billion in 2022 sales for its Covid-19 vaccine and therapeutic on Tuesday as the pharmaceutical giant reported a more than doubling of annual profits on strong sales of its innoculation.


Germany getting more vaccines for 'offensive' booster drive

Germany is scrambling to procure more vaccines to fuel what the new health minister on Thursday called a "very offensive" and fast booster strategy that would leave the country better prepared for the onslaught of the new ...


Germany's CureVac ditches first-generation COVID jab

Germany's CureVac said Tuesday it is no longer seeking European regulatory approval for its coronavirus vaccine, and will focus instead on a more promising second-generation jab.

page 1 from 5